In the present study, we observed that insulin and IGF-1, act as mitogens of colon cancer cells, activate the ERK1/2 and JNK MAPK signaling, resulting in cell cycle acceleration, cell growth and anti-apoptosis in colon cancer MC38 cells. Here, MAPK8 is linked to malignant colon neoplasm.